Stocks News

LAST PRICE
84.7700
TODAY'S CHANGE (%)
Trending Up0.6000 (0.7128%)

Bid / Lots
83.1800/ 1
Ask / Lots
86.5200/ 1
Open / Previous Close
84.8600 / 84.1700
Day Range
Low 83.4900
High 84.8600
52 Week Range
Low 56.6100
High 86.3600
Volume
164,910
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 21, 2024
- Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 4:08PM ET on Thursday Nov 21, 2024 by MT Newswires
  4:08PM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: PBH
  04:08 PM EST, 11/21/2024 (MT Newswires) -- Ronald M. Lombardi, Director, Chief Executive Officer, on November 19, 2024, sold 10,875 shares in Prestige Consumer Healthcare (PBH) for $898,241. Following the Form 4 filing with the SEC, Lombardi has con...
Nov 15, 2024
- Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: PBH
  03:27 AM EST, 11/15/2024 (MT Newswires) -- Christine Sacco, Chief Financial Officer, on November 12, 2024, sold 24,686 shares in Prestige Consumer Healthcare (PBH) for $2,024,499. Following the Form 4 filing with the SEC, Sacco has control over a to...
Nov 11, 2024
- DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: PBH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PBH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 11, 2024 11:48 ET (16:48 GMT)
Nov 7, 2024
- Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  09:05 AM EST, 11/07/2024 (MT Newswires) -- Prestige Consumer Healthcare (PBH) reported fiscal Q2 earnings Thursday of $1.09 per diluted share, up from $1.07 a year earlier. Analysts polled by Capital IQ expected $1.08. Total revenue for the quarter ...
- -- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  06:03 AM EST, 11/07/2024 (MT Newswires) -- ...

Yesterday
- HUTCHMED Announces Continued Inclusion of ORPATHYS(R) (savolitinib) in the National Reimbursement Drug List in China at Current Terms, from 5:30AM ET on Thursday Nov 28, 2024 by Dow Jones
  5:30AM ET on Thursday Nov 28, 2024 by Dow Jones
  Companies Mentioned: HCM
Nov 27, 2024
- DJ PTC Therapeutics Is Maintained at Outperform by Baird, from 8:19AM ET on Wednesday Nov 27, 2024 by Dow Jones
  8:19AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: PTCT
- PTC Therapeutics to Sell Rare Pediatric Disease Voucher for $150 Million, from 7:26AM ET on Wednesday Nov 27, 2024 by MT Newswires
  7:26AM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: PTCT
- PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million, from 7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire
  7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire
  Companies Mentioned: PTCT
- PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: PTCT
Nov 26, 2024
- PTC Therapeutics' Amyotrophic Lateral Sclerosis Trial Fails to Meet Endpoints; Shares Fall After Hours, from 5:23PM ET on Tuesday Nov 26, 2024 by MT Newswires
  5:23PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: PTCT
- DJ PTC Therapeutics to End Development of ALS Treatment, from 5:06PM ET on Tuesday Nov 26, 2024 by Dow Jones
  5:06PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: PTCT
- PTC Therapeutics Announces Topline Results of CardinALS Trial of Utreloxastat in ALS Patients, from 4:30PM ET on Tuesday Nov 26, 2024 by PR Newswire
  4:30PM ET on Tuesday Nov 26, 2024 by PR Newswire
  Companies Mentioned: PTCT
- PTC Therapeutics Announces Topline Results of CardinALS Trial of Utreloxastat in ALS Patients, from 4:30PM ET on Tuesday Nov 26, 2024 by Dow Jones
  4:30PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: PTCT
- Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference, from 4:05PM ET on Tuesday Nov 26, 2024 by Accesswire
  4:05PM ET on Tuesday Nov 26, 2024 by Accesswire
  Companies Mentioned: AMPH

Prestige Consumer Healthcare Inc
NYSE:PBHUnited States

Search Criteria

Nov 21, 2024

Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 4:08PM ET on Thursday Nov 21, 2024 by MT Newswires

Nov 15, 2024

Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 11, 2024

DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires

Peers Headlines

Yesterday

HUTCHMED Announces Continued Inclusion of ORPATHYS(R) (savolitinib) in the National Reimbursement Drug List in China at Current Terms, from 5:30AM ET on Thursday Nov 28, 2024 by Dow Jones

Nov 27, 2024

DJ PTC Therapeutics Is Maintained at Outperform by Baird, from 8:19AM ET on Wednesday Nov 27, 2024 by Dow Jones

PTC Therapeutics to Sell Rare Pediatric Disease Voucher for $150 Million, from 7:26AM ET on Wednesday Nov 27, 2024 by MT Newswires

PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million, from 7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire

PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

PTC Therapeutics' Amyotrophic Lateral Sclerosis Trial Fails to Meet Endpoints; Shares Fall After Hours, from 5:23PM ET on Tuesday Nov 26, 2024 by MT Newswires

DJ PTC Therapeutics to End Development of ALS Treatment, from 5:06PM ET on Tuesday Nov 26, 2024 by Dow Jones

PTC Therapeutics Announces Topline Results of CardinALS Trial of Utreloxastat in ALS Patients, from 4:30PM ET on Tuesday Nov 26, 2024 by PR Newswire

PTC Therapeutics Announces Topline Results of CardinALS Trial of Utreloxastat in ALS Patients, from 4:30PM ET on Tuesday Nov 26, 2024 by Dow Jones

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference, from 4:05PM ET on Tuesday Nov 26, 2024 by Accesswire